Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.

Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB.

J Am Acad Child Adolesc Psychiatry. 2000 Mar;39(3):292-9.

PMID:
10714048
2.

Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.

Sallee FR, Miceli JJ, Tensfeldt T, Robarge L, Wilner K, Patel NC.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):720-8.

PMID:
16721322
3.

A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.

Yoo HK, Joung YS, Lee JS, Song DH, Lee YS, Kim JW, Kim BN, Cho SC.

J Clin Psychiatry. 2013 Aug;74(8):e772-80. doi: 10.4088/JCP.12m08189.

PMID:
24021518
4.

Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.

Keck PE Jr, Reeves KR, Harrigan EP; Ziprasidone Study Group.

J Clin Psychopharmacol. 2001 Feb;21(1):27-35.

PMID:
11199944
5.

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR.

J Clin Psychiatry. 2001 Sep;62(9):707-14.

PMID:
11681767
6.

A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.

Nicolson R, Craven-Thuss B, Smith J, McKinlay BD, Castellanos FX.

J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):640-6.

PMID:
15968232
7.

Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.

Cutler AJ, Kalali AH, Weiden PJ, Hamilton J, Wolfgang CD.

J Clin Psychopharmacol. 2008 Apr;28(2 Suppl 1):S20-8. doi: 10.1097/JCP.0b013e318169d4ce.

PMID:
18334909
8.

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.

Potkin SG, Keck PE Jr, Segal S, Ice K, English P.

J Clin Psychopharmacol. 2005 Aug;25(4):301-10.

PMID:
16012271
9.
10.

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.

Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S.

J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):330-6.

PMID:
11886028
11.

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.

Keck P Jr, Buffenstein A, Ferguson J, Feighner J, Jaffe W, Harrigan EP, Morrissey MR.

Psychopharmacology (Berl). 1998 Nov;140(2):173-84.

PMID:
9860108
12.

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.

J Clin Psychiatry. 2001 Jan;62(1):50-6.

PMID:
11235929
13.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
14.

Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.

Ratner Y, Gibel A, Yorkov V, Ritsner MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1401-9. Epub 2007 Jun 21.

PMID:
17669574
15.

A placebo-controlled trial of risperidone in Tourette syndrome.

Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS.

Neurology. 2003 Apr 8;60(7):1130-5.

PMID:
12682319
16.

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.

Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP.

Psychopharmacology (Berl). 2001 May;155(2):128-34.

PMID:
11401000
17.
18.

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, Emrich HM.

Pharmacopsychiatry. 2002 Mar;35(2):57-61.

PMID:
11951146
19.

Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study.

Toren P, Weizman A, Ratner S, Cohen D, Laor N.

J Clin Psychiatry. 2005 Apr;66(4):499-503.

PMID:
15816793
20.

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF.

J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1147-52. Erratum in: J Am Acad Child Adolesc Psychiatry 1996 Mar;35(3):394.

PMID:
7559308

Supplemental Content

Support Center